ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares

8d ago, source:

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of ...

Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals

8d ago, source:

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $33.2, a high ...

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting

1d ago, source:

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings in Rett syndrome will be presented at the American Academy of Neurology ...

ACADIA Pharmaceuticals Inc ACAD

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Grabar Law Office Investigates Claims on Behalf of Shareholders of Acadia Pharmaceuticals Inc. (ACAD)

1mon ago, source: Business Insider

Philadelphia, Pennsylvania--(Newsfile Corp. - March 19, 2024) - Attention long-term investors of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD): A federal securities fraud complaint that filed on ...

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development

16d ago, source: Stockhouse

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development. Dr. Thompson will lead ...

Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

17d ago, source: ADVFN

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024 at 3:45 p.m ...

ACADIA Pharmaceuticals Inc ACAD

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development

16d ago, source: Business Wire

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development.

Acadia Pharmaceuticals Inc

4d ago, source: U.S. News & World Report

What Is a Stock Market Correction? Investors may be shaken by a drop of 10% or more in a stock market index, but corrections are par for the course.

ACADIA Pharmaceuticals Inc.

19d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...